Expertise in
2
conditions

Thomas Papathemelis

St. Marien Hospital
Amberg, BY, DE 
Expertise in
2
conditions
St. Marien Hospital
Amberg, BY, DE 

Overview

Thomas Papathemelis practices practicing medicine in Amberg, Germany.

Mr. Papathemelis is highly rated in 2 conditions, according to our data. His clinical expertise encompasses Endometrial Cancer, Fibroadenoma, Cervical Cancer, Lymphadenectomy, and Hysterectomy.

He is actively involved in clinical research, co-authoring 41 peer reviewed articles and participating in 1 clinical trial.

Gender

Male

Locations

St. Marien Hospital
Amberg, BY, Germany
Other Locations
Regensburg, BY, Germany
St Josefs Hospital Wiesbaden GmbH, Wiesbaden, Hessen, ST, Germany
Aachen, NW 52074, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Phase 3, Randomized, Double-blind, Multicenter Study of Dostarlimab (TSR-042) Plus Carboplatin-paclitaxel Versus Placebo Plus Carboplatin-paclitaxel in Patients With Recurrent or Primary Advanced Endometrial Cancer (RUBY)
A Phase 3, Randomized, Double-blind, Multicenter Study of Dostarlimab (TSR-042) Plus Carboplatin-paclitaxel Versus Placebo Plus Carboplatin-paclitaxel in Patients With Recurrent or Primary Advanced Endometrial Cancer (RUBY)
Enrollment Status: Active_not_recruiting
Publish Date: September 03, 2025
Intervention Type: Drug, Biological
Study Drugs: Dostarlimab, Carboplatin, Paclitaxel, Niraparib
Study Phase: Phase 3

41 Total Publications

Prognostic factors for lymph node infestation, long-term survival and recurrence rates in patients with vaginal cancer: a population-based study in Germany.
Prognostic factors for lymph node infestation, long-term survival and recurrence rates in patients with vaginal cancer: a population-based study in Germany.
Journal: Journal of cancer research and clinical oncology
Published: November 28, 2025

Frequently Asked Questions about Thomas Papathemelis

Is Thomas Papathemelis a top-rated expert for Lymphadenectomy?

MediFind is an objective health platform that identifies experts based on real-world data. Thomas Papathemelis is classified as an Distinguished expert for Lymphadenectomy, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Thomas Papathemelis participate in research or clinical trials?

Yes. Thomas Papathemelis has published 41 articles and abstracts on conditions like Lymphadenectomy. You can view a list of Thomas Papathemelis's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Papathemelis's expertise for a condition
ConditionClose
    View All 11 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile